Skip to main content
. Author manuscript; available in PMC: 2011 Jul 5.
Published in final edited form as: Am J Trop Med Hyg. 2008 May;78(5):736–740.

Table 3.

Potential adverse effects after treatment in patients in the study*

Characteristic Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Headache 1 (1.47) 3 (4.34) 3 (4.54) 2 (3.12) 3 (4.54) 3 (4.54)
Weakness 0 0 0 0 0 0
Dizziness 3 (4.41) 2 (2.89) 5 (7.57) 1 (1.56) 2 (3.03) 1 (1.51)
Anorexia 2 (2.94) 2 (2.89) 4 (6.06) 4 (6.05) 1 (1.51) 2 (3.03)
Nausea 2 (2.94) 1 (1.44) 2 (3.03) 1 (1.56) 1 (1.51) 1 (1.51)
Vomiting 1 (1.47) 0 1 (1.51) 0 0 1 (1.51)
Insomnia 0 0 0 0 0 0
Abdominal pain 3 (4.41) 4 (5.79) 1 (1.51) 2 (3.12) 2 (3.03) 3 (4.54)
Diarrhea 0 1 (1.44) 0 0 1 (1.51) 0
*

Values are no. (%).